American College Of Health Sciences |
| P.o. Box 16871 |
| Hattiesburg, MS 39404-6871 |
| General Phone: 601-467-0063 |
| Financial Aid Phone: 601-467-0063 |
| Sector: Private nonprofit, 4-year or above |
< Back
Latest American College Of Health Sciences News
Genzyme Delivers Strong Third-Quarter Results - Yahoo! News (press release)
Media Contact: Investor Contact: Bo Piela Sally Curley 617-768-6579 617-768-6140 GENZYME CORPORATION RECONCILIATION OF GAAP TO NON-GAAP EARNINGS Quarter Ended September 30, 2005 (Amounts in thousands, except per share data) Dilution Before Due to Charges, Contingently Amortization, Convertible FIN 46 & Debt Amorti- EITF 04-8 (EITF 04-8) zation IPR&D Income Statement Classification: Total revenues $ 708,063 Cost of products and services sold $(152,708) Selling, general and administrative $(201,830) Research and development $(120,834) Amortization of intangibles $ - $(50,847) Purchase of in-process research and development $ - $(12,700) Equity in income (loss) of equity method investments $ (2,728) Minority interest $ - Other $ (807) Investment income $ 8,073 Interest expense $ (6,749) Summary: Income (loss) before income taxes $ 230,480 $ - $(50,847) $(12,700) Provision for income taxes $ (69,991) $ - $ 18,712 $ - Net income allocated to Genzyme Stock $ 160,489 $ - $(32,135) $(12,700) Net income per share of Genzyme Stock: Basic $ 0.63 $ - $ (0.13) $ (0.05) Diluted (1) $ 0.61 $(0.01) $ (0.12) $ (0.05) Weighted average shares outstanding: Basic 256,490 - - - Diluted (1) 264,806 9,686 - - Income Statement Classification: NON-GAAP Before Effect Effect of GAAP of FIN 46 - more available